{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-084924","form_type":"8-K","ticker":null,"cik":"0001496323","company_name":"IGM Biosciences, Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.456452+00:00","generated_at":"2026-05-19T13:07:30.459279+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IGM Biosciences receives Nasdaq non-compliance notice for MVLS below $50M","bullets":["Received Nasdaq notice on June 6, 2025, for MVLS below $50M minimum requirement.","Has 180 calendar days, until December 3, 2025, to regain compliance.","Must have MVLS close at $50M+ for 10 consecutive business days to cure.","If non-compliance persists, Nasdaq may initiate delisting; company can appeal or consider transfer to Nasdaq Capital Market.","Listing continues under 'IGMS' with no immediate effect on trading."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-084924","json":"https://secwatch.observer/filing/0000950170-25-084924.json","markdown":"https://secwatch.observer/filing/0000950170-25-084924.md","text":"https://secwatch.observer/filing/0000950170-25-084924.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496323/000095017025084924/0000950170-25-084924-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496323/000095017025084924/igms-20250606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T13:07:30.459279+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a14a54ca48319b47b585cac4e6e770e30edf51d5","claim":"IGM Biosciences, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).","evidence_excerpt":"June 6, 2025, IGM Biosciences, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with the minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). The Notice has no effect at this time on the listing of the Company’s common stock (the “Common Stock”), which continues to trade on The Nasdaq Global Select Market under the symbol “IGMS”. In","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1496323/000095017025084924/0000950170-25-084924-index.htm","confidence":0.98,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5450(b)(2)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}